161 related articles for article (PubMed ID: 22952725)
21. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
[TBL] [Abstract][Full Text] [Related]
22. Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype.
Vidović D; Xie Y; Rinderspacher A; Deng SX; Landry DW; Chung C; Smith DH; Tautz L; Schürer SC
J Comput Aided Mol Des; 2011 Sep; 25(9):873-83. PubMed ID: 21904909
[TBL] [Abstract][Full Text] [Related]
23. The potential of PTPN22 as a therapeutic target for rheumatoid arthritis.
Carmona FD; Martín J
Expert Opin Ther Targets; 2018 Oct; 22(10):879-891. PubMed ID: 30251905
[TBL] [Abstract][Full Text] [Related]
24. Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening.
Hou X; Li R; Li K; Yu X; Sun JP; Fang H
J Med Chem; 2014 Nov; 57(22):9309-22. PubMed ID: 25372368
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.
Stanford SM; Krishnamurthy D; Falk MD; Messina R; Debnath B; Li S; Liu T; Kazemi R; Dahl R; He Y; Yu X; Chan AC; Zhang ZY; Barrios AM; Woods VL; Neamati N; Bottini N
J Med Chem; 2011 Mar; 54(6):1640-54. PubMed ID: 21341673
[TBL] [Abstract][Full Text] [Related]
26. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp.
Cohen S; Dadi H; Shaoul E; Sharfe N; Roifman CM
Blood; 1999 Mar; 93(6):2013-24. PubMed ID: 10068674
[TBL] [Abstract][Full Text] [Related]
27. Measuring the specific activity of the protein tyrosine phosphatase Lyp.
Bayley R; Yang P; Buckley CD; Young SP
J Immunol Methods; 2013 Feb; 388(1-2):33-9. PubMed ID: 23219421
[TBL] [Abstract][Full Text] [Related]
28. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling.
de la Puerta ML; Trinidad AG; Rodríguez Mdel C; de Pereda JM; Sánchez Crespo M; Bayón Y; Alonso A
PLoS One; 2013; 8(1):e54569. PubMed ID: 23359562
[TBL] [Abstract][Full Text] [Related]
29. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
van Oene M; Wintle RF; Liu X; Yazdanpanah M; Gu X; Newman B; Kwan A; Johnson B; Owen J; Greer W; Mosher D; Maksymowych W; Keystone E; Rubin LA; Amos CI; Siminovitch KA
Arthritis Rheum; 2005 Jul; 52(7):1993-8. PubMed ID: 15986374
[TBL] [Abstract][Full Text] [Related]
30. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.
Dai X; James RG; Habib T; Singh S; Jackson S; Khim S; Moon RT; Liggitt D; Wolf-Yadlin A; Buckner JH; Rawlings DJ
J Clin Invest; 2013 May; 123(5):2024-36. PubMed ID: 23619366
[TBL] [Abstract][Full Text] [Related]
31. PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant.
Zheng P; Kissler S
Diabetes; 2013 Mar; 62(3):896-904. PubMed ID: 23193190
[TBL] [Abstract][Full Text] [Related]
32. PSTPIP1-LYP phosphatase interaction: structural basis and implications for autoinflammatory disorders.
Manso JA; Marcos T; Ruiz-Martín V; Casas J; Alcón P; Sánchez Crespo M; Bayón Y; de Pereda JM; Alonso A
Cell Mol Life Sci; 2022 Feb; 79(2):131. PubMed ID: 35152348
[TBL] [Abstract][Full Text] [Related]
33. The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population.
Ramirez M; Quintana G; Diaz-Gallo LM; Caminos J; Garces M; Cepeda L; Rondon F; Restrepo JF; Egea E; Garavito G; Robledo G; Martin J; Iglesias-Gamarra A
Clin Exp Rheumatol; 2012; 30(4):520-4. PubMed ID: 22704547
[TBL] [Abstract][Full Text] [Related]
34. Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.
Kulkarni RA; Stanford SM; Vellore NA; Krishnamurthy D; Bliss MR; Baron R; Bottini N; Barrios AM
ChemMedChem; 2013 Sep; 8(9):1561-8. PubMed ID: 23873737
[TBL] [Abstract][Full Text] [Related]
35. R620W polymorphism of protein tyrosine phosphatase PTPN22 in Egyptian children and adolescents with systemic lupus erythematosus: relation to thyroid autoimmunity.
Hamza RT; Awwad KS; Temsah KA; Hamed AI
Int J Adolesc Med Health; 2013; 25(2):143-9. PubMed ID: 23314521
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of protein tyrosine phosphatase non-receptor N22 gene functional variant R620W in systemic lupus erythematosus patients from Kuwait: implications for disease susceptibility.
Al-Awadhi AM; Haider MZ; Sukumaran J; Balakrishnan S
BMC Rheumatol; 2018; 2():7. PubMed ID: 30886958
[TBL] [Abstract][Full Text] [Related]
37. A switch-variant model integrates the functions of an autoimmune variant of the phosphatase PTPN22.
Vang T; Nielsen J; Burn GL
Sci Signal; 2018 Apr; 11(526):. PubMed ID: 29666305
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors.
Liang X; Fu H; Xiao P; Fang H; Hou X
Bioorg Chem; 2020 Oct; 103():104124. PubMed ID: 32768742
[TBL] [Abstract][Full Text] [Related]
39. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity.
Machado-Contreras JR; Muñoz-Valle JF; Cruz A; Salazar-Camarena DC; Marín-Rosales M; Palafox-Sánchez CA
Clin Exp Med; 2016 Aug; 16(3):399-406. PubMed ID: 26013387
[TBL] [Abstract][Full Text] [Related]
40. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.
Zikherman J; Hermiston M; Steiner D; Hasegawa K; Chan A; Weiss A
J Immunol; 2009 Apr; 182(7):4093-106. PubMed ID: 19299707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
